Found 108 matching trials
OPT-CAD Score GUIded Dual ANtiplatelet De-esCalation Time NA Monotherapy with a P2Y12 inhibitor after a minimum period of DAPT following...
Show More Location
General Hospital of Northern Theater Command
Learn More & Join Trial
Evaluation of a Modified Anti-Platelet Therapy Associated With Low-dose DES Firehawk in Acute Myocardial Infarction Patients Treated With Complete Revascularization Strategy NA The study aims to evaluate a modified antiplatelet therapy associated with ...
Show More Location
Universitätsklinikum
Learn More & Join Trial
XIENCE 28 USA Study NA The XIENCE 28 USA Study is prospective, single arm, multi-center, open labe...
Show More Location
Heart Center Research, LLC
Learn More & Join Trial
Efficacy and Safety of Nano+ Polymer-free Sirolimus-Eluting Stent: A Optical Coherent Tomography Study PHASE4 Our hypothesis is to test that 1) The safety and efficacy of Nano+ DES in p...
Show More Location
UZ Virga Jesse Ziekenhuis
Learn More & Join Trial
EDUCATE: The MEDTRONIC Endeavor Drug Eluting Stenting: Understanding Care, Antiplatelet Agents and Thrombotic Events PHASE4 EDUCATE is a prospective, multi-center study designed to collect real-world...
Show More Location
AnMed Health Medical Center
Learn More & Join Trial
Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD) PHASE4 This study is a prospective, multicenter, parallel, open-label, randomized,...
Show More Location
Xinqiao Hospital, Army Medical University
Learn More & Join Trial
ACCEL-LOADING-ACS Study PHASE4 The purpose of this study is to determine whether adjunctive cilostazol loa...
Show More Location
Gyeonsang National University Hospital
Learn More & Join Trial
Comparison Of Reduced DAPT Followed by P2Y12 Inhibitor Monotherapy With Prasugrel vs stAndard Regimen in STEMI Patients PHASE4 The study is a multi-centre, Open-label, Randomized Controlled, 1:1 trial c...
Show More Learn More & Join Trial
Plasma and Platelet microRNAs in Clopidogrel Low Response Patients PHASE4 Clopidogrel is an important anti-platelet agent.However, about 30% of the c...
Show More Location
First Affiliated Hospital of Nanjing Medical University
Learn More & Join Trial
Optimization and Validation of Quality Control Indicators for Coronary Revascularization Based on Antiplatelet Therapy N/A Study Purpose Coronary heart disease (CAD) is a leading global cause of dea...
Show More Location
General Hospital of Northern Theater Command
Learn More & Join Trial